| Literature DB >> 26295226 |
Wun-Jie Lin1,2, Tung-Ying Wu3, Tzu-Rong Su4,5, Zhi-Hong Wen6, Jih-Jung Chen7, Lee-Shing Fang8, Yang-Chang Wu9,10,11,12, Ping-Jyun Sung13,14,15,16,17.
Abstract
Two eudesmane sesquiterpenoids, verticillatol (1) and 5α-acetoxy-4(14)-eudesmene-1β-ol (2) and two cembrane diterpenoids, (-)-leptodiol acetate (3) and sinulacembranolide A (4) were isolated from the octocoral Sinularia gaweli and compounds 2-4 are new isolates. The structures of new terpenoids 2-4 were elucidated by spectroscopic methods and by comparison the spectral data with those of known analogues. Terpenoid 4 was found to inhibit the accumulation of the pro-inflammatory inducible nitric oxide synthase (iNOS) protein of the lipopolysaccharide (LPS)-stimulated RAW264.7 marcophage cells.Entities:
Keywords: Sinularia gaweli; cembrane; eudesmane; iNOS; octocoral
Mesh:
Substances:
Year: 2015 PMID: 26295226 PMCID: PMC4581310 DOI: 10.3390/ijms160819508
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The soft coral Sinularia gaweli and the structures of verticillatol (1); 5α-acetoxy-4(14)-eudesmene-1β-ol (2); (–)-leptodiol acetate (3); and sinulacembranolide A (4).
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data, 1H–1H COSY and HMBC correlations for sesquiterpenoid 2.
| Position | δH Multiplicity ( | δC, Multiplicity | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 4.00 dd (12.0, 4.8) | 72.9, CH | H2-2 | C-2, -10, -15 |
| 2α | 1.85 m | 30.9, CH2 | H-1, H-2β, H2-3 | n. o. |
| β | 1.55 m | – | H-1, H-2α, H2-3 | C-1, -3 |
| 3α | 2.22 m | 30.2, CH2 | H2-2, H-3β | C-1, -2, -4, -5, -14 |
| β | 1.26 m | – | H2-2, H-3α | n. o. |
| 4 | – | 145.1, C | – | – |
| 5 | – | 87.3, C | – | – |
| 6α | 2.61 br d (14.4) | 28.5, CH2 | H-6β | C-5, -10 |
| β | 1.41 dd (14.4, 12.4) | H-6α, H-7 | C-7, -8 | |
| 7 | 1.26 m | 38.6, CH | H2-6, H2-8, H-11 | C-9 |
| 8α | 1.22 m | 23.6, CH2 | H-7, H-8β, H2-9 | C-7, -9 |
| β | 1.59 m | – | H-7, H-8α, H2-9 | n. o. |
| 9 | 1.70 m | 30.4, CH2 | H2-8 | C-7, -8, -15 |
| 10 | – | 43.3, C | – | – |
| 11 | 1.47 m | 32.5, CH | H-7, H3-12, H3-13 | C-8 |
| 12 | 0.90 d (6.8) | 19.6, CH3 | H-11 | C-7, -11, -13 |
| 13 | 0.89 d (6.8) | 19.9, CH3 | H-11 | C-7, -11, -12 |
| 14a | 5.05 s | 111.6, CH2 | H-14b | C-3, -5 |
| b | 4.90 s | – | H-14a | C-3, -4, -5 |
| 15 | 0.79 s | 12.3, CH3 | – | C-1, -5, -9, -10 |
| 5-OAc (5a) (the C=O) | – | 168.9, C | – | – |
| 5-OAc (5b) (the Me) | 2.03 s | 21.8, CH3 | – | C-5a |
n. o. = not observed; COSY = correlation spectroscopy; HMBC = heteronuclear multiple bond connectivity; 5a = acetate carbonyl of 5-acetoxy group; 5b = acetate methyl of 5-acetoxy group.
Figure 2Important nuclear overhauser effect spectroscopy (NOESY) correlations for compound 2.
1H (400 MHz, CDCl3) and 13C (100 MHz, CDCl3) NMR data, 1H–1H COSY and HMBC correlations for cembrane 4.
| Position | δH Multiplicity ( | δC, Multiplicity | 1H–1H COSY | HMBC |
|---|---|---|---|---|
| 1 | 2.32 ddd (10.8, 10.8, 3.2) | 41.5, CH | H2-2, H2-14 | C-17 |
| 2α | 2.82 d (15.2) | 31.9, CH2 | H-2β | C-1, -3, -4, -14, -15 |
| β | 3.57 dd (15.2, 10.8) | – | H-1, H-2α | C-1, -14 |
| 3 | – | 160.9, C | – | – |
| 4 | 115.5, C | – | – | |
| 5 | 6.65 d (0.8) | 109.1, CH | H-7 | C-3, -4, -6 |
| 6 | – | 149.2, C | – | – |
| 7 | 5.54 br s | 76.1, CH | H-5 | C-5, -6, -8, -9, -19, -7a |
| 8 | – | 72.6, C | – | – |
| 9α | 1.91 dd (14.8, 11.2) | 42.9, CH2 | H-9β, H-10 | C-7, -8, -10 |
| β | 2.67 dd (14.8, 5.6) | – | H-9α, H-10 | C-7, -8, -10, -11 |
| 10 | 4.95 ddd (11.2, 5.6, 1.2) | 77.6, CH | H2-9, H-11 | C-9, -11, -12 |
| 11 | 6.16 d (1.2) | 154.0, CH | H-10 | C-10, -12, -13, -20 |
| 12 | – | 129.8, C | – | – |
| 13 | 5.52 dd (11.2, 4.8) | 66.7, CH | H2-14 | C-11, -12, -14, -13a |
| 14α | 2.63 ddd (11.2, 11.2, 3.2) | 36.1, CH2 | H-1, H-13, H-14β | n. o. |
| β | 1.90 ddd (11.2, 10.8, 4.8) | – | H-1, H-13, H-14α | C-1, -2, -12, -13 |
| 15 | – | 148.4, C | – | – |
| 16 | 4.82 br s | 110.6, CH2 | H3-17 | C-1, -15, -17 |
| 17 | 1.81 s | 20.7, CH3 | H2-16 | C-1, -15, -16 |
| 18 | – | 163.5, C | – | – |
| 19 | 1.47 s | 20.1, CH3 | – | C-7, -8, -9 |
| 20 | – | 169.5, C | – | – |
| 7-OAc (7a) (the C = O) | – | 169.6, C | – | – |
| 7-OAc (7b) (the Me) | 2.17 s | 20.9, CH3 | – | C-7a |
| 13-OAc (13a) (the C = O) | – | 170.3, C | – | – |
| 13-OAc (13b) (the Me) | 1.99 s | 21.0, CH3 | – | C-13a |
| 18-OCH3 | 3.88 s | 51.9, CH3 | – | C-18 |
n. o. = not observed; 7a = acetate carbonyl of 7-acetoxy group; 7b = acetate methyl of 7-acetoxy group; 13a = acetate carbonyl of 13-acetoxy group; 13b = acetate methyl of 13-acetoxy group.
Figure 3NOESY (nuclear overhauser effect spectroscopy) correlations of compound 4.
Figure 4Effects of compounds 1–4 on pro-inflammatory iNOS and COX-2 protein expression in LPS-stimulated murine macrophage cell line RAW264.7. (A) Relative density of iNOS immunoblot; (B) relative density of COX-2 immunoblot. The relative intensity of the LPS-stimulated group was taken to be 100%. Band intensities were quantified by densitometry and are indicated as the percent change relative to that of the LPS-stimulated group. Compound 4 and dexamethasone (Dex.) significantly inhibited LPS-induced iNOS protein expression in macrophage. The experiment was repeated three times. (* p < 0.05, significantly different from the LPS-stimulated group).